A Single-Arm, Expanded Access Study of Zanubrutinib in Participants With B-cell Malignancies | BeOne Medicines

A Single-Arm, Expanded Access Study of Zanubrutinib in Participants With B-cell Malignancies

Beigene Study ID

BGB-3111-216

ClinicalTrials.gov ID

NCT04052854

Study Overview

Sex: All

Age: 18 Years / N/A

Accepts Healthy Volunteers? yes

No Study Documents

Study Overview

Sex: All

Age: 18 Years / N/A

Accepts Healthy Volunteers? yes

No Study Documents